| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |